In addition, ATRAP activation therapy in insulin target organs (e.g., adipose tissue and skeletal muscle tissue) may be widely applied for treating lifestyle diseases that are not accompanied by obesity or hypertension. This evidence concerns the gene AGTRAP and obesity disorder.